Antitrichomonal activity of δ opioid receptor antagonists, 7-benzylidenenaltrexone derivatives.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2017-08-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2017.06.026PMID 28662966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between high risk human papillomavirus infection and co-infection with Candida spp. and Trichomonas vaginalis in women with cervical premalignant and malignant lesions.

  2017cited by this paper
• Trichomonas vaginalis: a possible foe to prostate cancer

  2016cited by this paper
• Investigation of 7-benzylidenenaltrexone derivatives as a novel structural antitrichomonal lead compound.

  2015cited by this paper
• Neglected Parasitic Infections in the United States: Trichomoniasis

  2014cited by this paper
• Circumcision and prostate cancer: a population-based case-control study in Montréal, Canada

  2014cited by this paper
• The Effect of Immunodeficiency on the Evolution of Virulence: An Experimental Test with the Rodent Malaria Plasmodium chabaudi*

  2014cited by this paper
• Essential structure of the κ opioid receptor agonist nalfurafine for binding to the κ receptor.

  2014cited by this paper
• Investigation of 7-benzylidenenaltrexone derivatives as resistance reverser for chloroquine-resistant Plasmodium chabaudi.

  2012cited by this paper
• Structure of the δ-opioid receptor bound to naltrindole

  2012cited by this paper
• The Revised Classification of Eukaryotes

  2012cited by this paper
• Synthesis of novel basic skeletons derived from naltrexone.

  2011cited by this paper
• Ultrastructural features of Tritrichomonas mobilensis and comparison with Tritrichomonas foetus.

  2011cited by this paper
• Opioid δ₁ receptor antagonist 7-benzylidenenaltrexone as an effective resistance reverser for chloroquine-resistant Plasmodium chabaudi.

  2011cited by this paper
• Opioids in preclinical and clinical trials.

  2011cited by this paper
• Trichomoniasis: evaluation to execution.

  2011cited by this paper
• Design and synthesis of KNT-127, a δ-opioid receptor agonist effective by systemic administration.

  2010cited by this paper
• Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study.

  2009cited by this paper
• Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial

  2009cited by this paper
• Design, synthesis, and structure-activity relationship of novel opioid kappa-agonists.

  2008cited by this paper
• Trichomoniasis and its treatment

  2006cited by this paper
• Alternative Pathway of Metronidazole Activation in Trichomonas vaginalis Hydrogenosomes

  2005cited by this paper
• Syntheses and receptor-binding studies of derivatives of the opioid antagonist naltrexone.

  2004cited by this paper
• Treatment of Infections Caused by Metronidazole-Resistant Trichomonas vaginalis

  2004cited by this paper
• Reactivity of Reduced [2Fe-2S] Ferredoxins Parallels Host Susceptibility to Nitroimidazoles

  2003cited by this paper
• Metronidazole-resistant strains of Trichomonas vaginalis display increased susceptibility to oxygen

  2001cited by this paper
• Drug Targets and Mechanisms of Resistance in the Anaerobic Protozoa

  2001cited by this paper
• Glutathione‐S‐transferase activity in malarial parasites

  1999cited by this paper
• Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs.

  1999cited by this paper
• Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action.

  1998cited by this paper
• Discovery of a structurally novel opioid kappa-agonist derived from 4,5-epoxymorphinan.

  1998cited by this paper
• 7-Arylidenenaltrexones as Selective δ1 Opioid Receptor Antagonists

  1998cited by this paper
• 7-Arylidenenaltrexones as selective delta1 opioid receptor antagonists.

  1998cited by this paper
• Synthesis and stereochemical assignment of 7‐arylidene and 7‐heteroarylidene morphinan‐6‐ones

  1996cited by this paper
• Plasmodium berghei: implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo.

  1995cited by this paper
• Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist.

  1994cited by this paper
• Metronidazole and drug resistance.

  1993cited by this paper
• Reduced transcription of the ferredoxin gene in metronidazole-resistant Trichomonas vaginalis.

  1992cited by this paper
• Role of the spacer in conferring kappa opioid receptor selectivity to bivalent ligands related to norbinaltorphimine.

  1991cited by this paper
• Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.

  1991cited by this paper
• Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites.

  1989cited by this paper
• Basic properties of Tritrichomonas mobilensis hemagglutinin

  1988cited by this paper
• Application of the message-address concept in the design of highly potent and selective non-peptide delta opioid receptor antagonists.

  1988cited by this paper
• Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity.

  1988cited by this paper
• Identification and characterization of the opiate receptor in the ciliated protozoan, Tetrahymena

  1988cited by this paper
• Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.

  1988cited by this paper
• Cell culture compared with broth for detection of Trichomonas vaginalis

  1987cited by this paper
• Ferredoxin-dependent reduction of nitroimidazole derivatives in drug-resistant and susceptible strains of Trichomonas vaginalis.

  1986cited by this paper
• Inhibition of hydrogen production in drug-resistant and susceptible Trichomonas vaginalis strains by a range of nitroimidazole derivatives.

  1986cited by this paper
• [D-Pen2,D-Pen5]enkephalin (DPDPE): a delta-selective enkephalin with low affinity for mu 1 opiate binding sites.

  1986cited by this paper
• [D-Pen2,D-Pen5]enkephalin (DPDPE): a δ-selective enkephalin with low affinity for μ1 opiate binding sites

  1986cited by this paper
• Detection and cultivation of intestinal trichomonads of squirrel monkeys (Saimiri sciureus)

  1985cited by this paper
• Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissues.

  1984cited by this paper
• Review Special Issue on Sexually Transmitted Infections Trichomoniasis – Are We Giving the Deserved Attention to the Most Common Non-viral Sexually Transmitted Disease Worldwide?

  year unknowncited by this paper

• A Two-Step Process for the Synthesis of Densely Functionalized N-Bridged Octahydrobenzofurans and Hexahydrobenzofurans.

  2025cites this paper
• Design and synthesis of unique morphinan-type molecules: Their application to the search for the unexplored binding domain between opioid receptors and morphinan ligands.

  2024cites this paper
• Unexpected Rearrangement Reactions of the 14-Aminonaltrexone Skeleton.

  2023cites this paper
• Morphine alkaloids: History, biology, and synthesis.

  2021cites this paper
• Structure-Activity Relationship between Thiol Group-Trapping Ability of Morphinan Compounds with a Michael Acceptor and Anti-Plasmodium falciparum Activities

  2020cites this paper
• Essential structure of orexin 1 receptor antagonist YNT-707, part V: Structure-activity relationship study of the substituents on the 17-amino group.

  2019cites this paper
• Endogenous Opiates and Behavior: 2017.

  2019cites this paper
• Favorskii-Type Rearrangement of the 4,5-Epoxymorphinan Skeleton.

  2018cites this paper